NOBLE - An Open Label, Randomized, Controlled, Phase 2 Study to Evaluate the Safety and Efficacy of Pegcetacoplan In The Treatment Of Post-Transplant Recurrence of C3G or IC-MPGN

  • Kanellis, John (Primary Chief Investigator (PCI))

Project: Research

Project Details

Effective start/end date15/06/2114/06/26


  • clinical trial
  • phase 2 study
  • treatment safety
  • treatment efficacy
  • kidney transplantation